Charles River Laboratories International Inc (CRL) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Charles River Laboratories International inc   (NYSE: CRL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Charles River Laboratories International Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 26 2026, Charles River Laboratories International Inc has not recorded any inventories.
Visit Charles River Laboratories International Inc Balance sheet

Within Healthcare sector 69 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 432 in the second quarter 2026, to 519.

CRL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Charles River Laboratories International Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRL Inventory Turnover Ratio (Sep 26 2026)
III. Quarter		 (Jun 27 2026)
II. Quarter		 (Mar 28 2026)
I. Quarter		 (Dec 27 2025)
IV. Quarter		 (Sep 27 2025)
III. Quarter
Y / Y Inventory Growth 5.65 % 23.86 % 23.98 % 7.38 % -10.01 %
Y / Y Cost of Sales Growth - - 5.45 % 2047.49 % -13.33 %
Inventory Turnover Ratio (TTM) - - 7.56 7.9 6.12
CRL's Total Ranking # 519 # 432 # 359 # 320 #
Average inventory processing period - - 48 46 60
Seq. Inventory Growth -7.69 % -3.74 % 20.27 % -1.14 % 8.23 %
Seq. Cost of Sales Growth - - 5.02 % 1.25 % -2.09 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 6
Healthcare Sector # 70
Overall Market # 519

Inventory Turnover Ratio Statistics
High Average Low
10.76 7.84 5.39
(Sep 28 2013)   (Jun 27 2026)



CRL Company Profile >> Back to CRL Efficiency Comparisons >> Compare CRL Inventory Turnover Ratio to its Competitors

Financial Statements
Charles River Laboratories International Inc 's Inventories $ 320 Millions Visit CRL's Balance sheet
Charles River Laboratories International Inc 's Cost of Revenues TTM $ 1,189 Millions Visit CRL's Income Statement
What are CRL's Sales? Visit CRL's Sales by Segment

Other Inventory Turnover Ratios
Charles River Laboratories International Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CRL's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CRL's Competitors
Inventory Turnover Ratio for CRL's Suppliers
Inventory Turnover Ratio for CRL's Customers

You may also want to know
CRL's Sales Growth Rates CRL's Pe Price to earnings ratio CRL's Receivables Turnover Ratio CRL's Stock Quote
CRL's Net Income Growth Rates CRL's Ps Price to Sales ratio CRL's Sales per Employee CRL's Asset Turnover Ratio
CRL's Net Margin CRL's Pb Price to Book ratio CRL's Financial Strength Ratios CRL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 26 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 26 2026 Inventories at quarter ending Sep 26 2026
Lantheus Holdings Inc   9.76 $ 604.826  Millions$ 62  Millions
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Cardiff Lexington Corporation  6.98 $ 3.768  Millions$ 1  Millions
Carlsmed Inc   6.91 $ 15.844  Millions$ 2  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Myomo Inc   4.58 $ 14.802  Millions$ 3  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions

Date modified: 2026-11-05T14:33:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.